Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01069575
Recruitment Status : Unknown
Verified September 2013 by Yataro Daigo, Shiga University.
Recruitment status was:  Recruiting
First Posted : February 17, 2010
Last Update Posted : September 18, 2013
Human Genome Center, Institute of Medical Science, University of Tokyo
Information provided by (Responsible Party):
Yataro Daigo, Shiga University

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2015
  Estimated Study Completion Date : October 2015